Approval · Notice of Compliance 2945 · 2004
ALIMTA: Notice of Compliance 2945
Issued May 21, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2945
- Date
- May 21, 2004
- Company
- Eli Lilly Canada IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Antineoplastic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALIMTA | 02253437 | Cancelled Post Market |
Medicinal ingredients
- PEMETREXED DISODIUM 500 MG per VIAL